Evidence map›Paper›PMID 41446853›Full record

ArticleFrontiers in medicine2025

Comparison of antibiotic resistance and molecular characteristics of

Sipei Wang, Sheng Zhao, Tinghua Ye, Xingxing Lou, Xinling Pan

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sipei WangDepartment of Clinical Laboratory, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, Zhejiang, China.
Sheng ZhaoDepartment of Clinical Laboratory, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, Zhejiang, China.
Tinghua YeDepartment of Clinical Laboratory, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, Zhejiang, China.
Xingxing LouDepartment of Clinical Laboratory, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, Zhejiang, China.
Xinling PanDepartment of Biomedical Sciences Laboratory, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Three patient groups were prospectively and consecutively enrolled, including: the BSI-B group (UTI with concurrent bacteremia), the UTI-U group (UTI without bacteremia), and the ASB-U group (asymptomatic bacteriuria). All isolated strains were confirmed as Results: There were 50 cases for each group enrolled in this study. The UTI-U isolates demonstrated significantly higher resistance rates to aztreonam (28.00% vs. 8.00%), ceftazidime (20.00% vs. 4.00%), cefepime (16.00% vs. 2.00%), and gentamicin (30.00% vs. 12.00%) compared to the BSI-B group ( Conclusion:

Indexed as

antibiotic resistanceasymptomatic bacteriuriabloodstream infectionE. coliurinary tract infectionvirulence factor

Identifiers

PMID41446853
PMCPMC12722795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.